SignatureFD’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.12K | Sell |
500
-32
| -6% | -$566 | ﹤0.01% | 2598 |
|
|
2025
Q4 | $9.95K | Buy |
532
+447
| +526% | +$7.42K | ﹤0.01% | 2434 |
|
|
2025
Q3 | $1.24K | Hold |
85
| – | – | ﹤0.01% | 3043 |
|
|
2025
Q2 | $938 | Hold |
85
| – | – | ﹤0.01% | 3034 |
|
|
2025
Q1 | $759 | Hold |
85
| – | – | ﹤0.01% | 3105 |
|
|
2024
Q4 | $800 | Hold |
85
| – | – | ﹤0.01% | 3068 |
|
|
2024
Q3 | $685 | Sell |
85
-232
| -73% | -$2.01K | ﹤0.01% | 3056 |
|
|
2024
Q2 | $2.69K | Sell |
317
-269
| -46% | -$2.43K | ﹤0.01% | 2683 |
|
|
2024
Q1 | $5.26K | Sell |
586
-122
| -17% | -$1.13K | ﹤0.01% | 2516 |
|
|
2023
Q4 | $7.96K | Buy |
708
+554
| +360% | +$5.58K | ﹤0.01% | 2355 |
|
|
2023
Q3 | $1.33K | Sell |
154
-13
| -8% | -$126 | ﹤0.01% | 2881 |
|
|
2023
Q2 | $1.73K | Sell |
167
-10
| -6% | -$110 | ﹤0.01% | 2851 |
|
|
2023
Q1 | $1.92K | Sell |
177
-344
| -66% | -$3.64K | ﹤0.01% | 2816 |
|
|
2022
Q4 | $5.85K | Buy |
521
+71
| +16% | +$746 | ﹤0.01% | 2401 |
|
|
2022
Q3 | $5K | Buy |
450
+9
| +2% | +$84 | ﹤0.01% | 2469 |
|
|
2022
Q2 | $4K | Sell |
441
-53
| -11% | -$488 | ﹤0.01% | 2550 |
|
|
2022
Q1 | $5K | Buy |
494
+185
| +60% | +$1.81K | ﹤0.01% | 2514 |
|
|
2021
Q4 | $3K | Buy |
309
+154
| +99% | +$1.34K | ﹤0.01% | 2620 |
|
|
2021
Q3 | $1K | Sell |
155
-5
| -3% | -$56 | ﹤0.01% | 2930 |
|
|
2021
Q2 | $2K | Sell |
160
-198
| -55% | -$3.72K | ﹤0.01% | 2622 |
|
|
2021
Q1 | $7K | Buy |
358
+276
| +337% | +$5.25K | ﹤0.01% | 2027 |
|
|
2020
Q4 | $1K | Hold |
82
| – | – | ﹤0.01% | 2482 |
|
|
2020
Q3 | $1K | Buy |
82
+23
| +39% | +$431 | ﹤0.01% | 2499 |
|
|
2020
Q2 | $1K | Buy |
+59
| New | +$1.52K | ﹤0.01% | 2386 |
|
|
2018
Q3 | – | Sell |
-200
| Closed | -$5K | – | 2003 |
|
|
2018
Q2 | $5K | Buy |
+200
| New | +$4.75K | ﹤0.01% | 1568 |
|
Other funds holding TBPH
MAP
WAM
NM
ICM
VCM
